MeSH D006069 - gonorrhea
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| A.H. Robins Company | Erythromycin lactobionate | Erythromycin |  | 1985-03-28 |  |  |
| Erythromycin | Robimycin |  | 1982-01-01 |  |  | |
| Abbott Biotherapeutics | Erythromycin lactobionate | Erythrocin |  | 1988-01-04 |  |  |
| Alembic Pharmaceuticals | Moxifloxacin | Moxifloxacin |  | 2019-02-13 |  |  |
| Erythromycin | Erythromycin |  | 2023-08-24 |  |  | |
| ALK-Abelló | Ciprofloxacin | Otiprio | 2029-04-21 | 2015-12-10 |  |  |
| Alkem Laboratories | Cefixime | Cefixime |  | 2018-10-09 |  |  |
| Erythromycin | Erythromycin |  | 2022-07-13 |  |  | |
| Allergan | Ciprofloxacin | Ciprofloxacin |  | 2005-01-21 |  |  |
| Alpharma | Erythromycin | Erythromycin |  | 1982-04-19 |  |  |
| Erythromycin lactobionate | Erythromycin Ethylsuccinate |  | 1982-01-01 |  |  | |
| Alra | Erythromycin lactobionate, Sulfisoxazole acetyl | Eryzole |  | 1988-06-15 |  |  |
| Altaire Pharmaceuticals | Ciprofloxacin | Ciprofloxacin |  | 2018-05-03 |  |  |
1
2
3
4
5
6
...
14
>
Clinical Trials
Historical Success Rate
Phase 1
80%4/5
Phase 2
70%7/10
Phase 3
79%33/42
Approved: 29Overall Success rate: 44%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
...
9
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use